Skip to main content

We may have been right on Senate stem cell vote

In December, following the November US midterm elections, Richard Gallagher, the editor of The Scientist, wrote a linkurl:hopeful editorial;https://www.the-scientist.com/article/display/36654/ on the future of stem cell funding in the US. In it, he suggested that the Senate was just one vote shy of the 67-33 vote it would need to overturn a Presidential veto on the bill. He may have been right. Yesterday, the Senate voted 63-34 to approve the Stem Cell Research Enhancement Act. The three senator

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
In December, following the November US midterm elections, Richard Gallagher, the editor of The Scientist, wrote a linkurl:hopeful editorial;https://www.the-scientist.com/article/display/36654/ on the future of stem cell funding in the US. In it, he suggested that the Senate was just one vote shy of the 67-33 vote it would need to overturn a Presidential veto on the bill. He may have been right. Yesterday, the Senate voted 63-34 to approve the Stem Cell Research Enhancement Act. The three senators who didn't vote -- Connecticut's Chris Dodd, South Dakota's Tim Johnson (still recovering from a brain hemorrhage), and Louisiana's Mary Landrieu -- are all Democrats who voted for the bill last year. If all three voted for the bill again this year, Richard would be right. But that's not the important thing; the important thing is that President Bush has promised to veto this bill too, despite the Senate vote and a vote approving the bill by the US House of Representatives in January. That means the state of federal funding for stem cell research will remain the same as it's been since August 9, 2001, when Bush announced his restrictions on funding. Some are saying that the Hope Act, a second bill passed today 70-28 by the Senate, which encourages the use of 'naturally dead embryos,' will oil the gears a bit. Scientists, however, have said that's a misguided approach. It looks as though stem cell research supporters will have to muster their efforts for the 2008 presidential election.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo